What type of study is this?

This is a Literature Review study.

October 31, 2025CancersOpen Access

Cutaneous Squamous Cell Carcinoma in Immunocompromised Patients

View Full Paper

Ask AI

Bookmark

Authors

SHSoo Hyun HwangUniversity of California, Los Angeles MJMaie A. St. JohnJohns Hopkins University

Discussion

Member takes

Implication

This review demonstrates treatment challenges in cutaneous squamous cell carcinoma among immunocompromised patients, suggesting a need for improved protocols.

Key Points

Immunosuppressed patients face increased mortality from cutaneous squamous cell carcinoma due to limited treatment options.
Clinical focus on cutaneous squamous cell carcinoma in immunocompromised individuals shows an urgent need for better management strategies.
Observational analysis highlights knowledge gaps in current cSCC treatment for immunocompromised patients, calling for research initiatives.
National Comprehensive Cancer Network guidelines underscore the need for standardized protocols in high-risk patients with cSCC.

Cite This Study

Hwang et al. (2025) studied this question.

synapsesocial.com/papers/6903fee5b25c631a4265fec8 https://doi.org/10.3390/cancers17213476

View Full Paper

Ask AI

Bookmark

Implication

This review demonstrates treatment challenges in cutaneous squamous cell carcinoma among immunocompromised patients, suggesting a need for improved protocols.

Cutaneous Squamous Cell Carcinoma in Immunocompromised Patients

Discussion

Member takes

Implication

Key Points

Cite This Study

Cutaneous Squamous Cell Carcinoma in Immunocompromised Patients

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider